These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 39000346)

  • 1. Creation of an Isogenic Human iPSC-Based RGC Model of Dominant Optic Atrophy Harboring the Pathogenic Variant c.1861C>T (p.Gln621Ter) in the
    García-López M; Jiménez-Vicente L; González-Jabardo R; Dorado H; Gómez-Manjón I; Martín MÁ; Ayuso C; Arenas J; Gallardo ME
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells.
    Sladen PE; Jovanovic K; Guarascio R; Ottaviani D; Salsbury G; Novoselova T; Chapple JP; Yu-Wai-Man P; Cheetham ME
    Hum Mol Genet; 2022 Oct; 31(20):3478-3493. PubMed ID: 35652445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function.
    Lei Q; Xiang K; Cheng L; Xiang M
    Stem Cell Reports; 2024 Jan; 19(1):68-83. PubMed ID: 38101398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy.
    Ahuja AS; Selvam P; Vadlamudi C; Chopra H; Richter JE; Macklin SK; Samreen A; Helmi H; Mohammaad AN; Hines S; Davila MC; Atwal PS; Caulfield TR
    Ophthalmic Genet; 2020 Dec; 41(6):563-569. PubMed ID: 32940104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OPA1-associated disorders: phenotypes and pathophysiology.
    Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Opa1 Mutation on Survival and Function of Retinal Ganglion Cells.
    González-Menéndez I; Reinhard K; Tolivia J; Wissinger B; Münch TA
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4835-45. PubMed ID: 26218912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.
    Formichi P; Radi E; Giorgi E; Gallus GN; Brunetti J; Battisti C; Rufa A; Dotti MT; Franceschini R; Bracci L; Federico A
    J Neurol Sci; 2015 Apr; 351(1-2):99-108. PubMed ID: 25796301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy.
    Mayorov VI; Lowrey AJ; Biousse V; Newman NJ; Cline SD; Brown MD
    BMC Biochem; 2008 Sep; 9():22. PubMed ID: 18783614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opa1 Deficiency Leads to Diminished Mitochondrial Bioenergetics With Compensatory Increased Mitochondrial Motility.
    Sun S; Erchova I; Sengpiel F; Votruba M
    Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):42. PubMed ID: 32561926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling autosomal dominant optic atrophy using induced pluripotent stem cells and identifying potential therapeutic targets.
    Chen J; Riazifar H; Guan MX; Huang T
    Stem Cell Res Ther; 2016 Jan; 7():2. PubMed ID: 26738566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy.
    Alavi MV; Bette S; Schimpf S; Schuettauf F; Schraermeyer U; Wehrl HF; Ruttiger L; Beck SC; Tonagel F; Pichler BJ; Knipper M; Peters T; Laufs J; Wissinger B
    Brain; 2007 Apr; 130(Pt 4):1029-42. PubMed ID: 17314202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recurrent deletion mutation in OPA1 causes autosomal dominant optic atrophy in a Chinese family.
    Zhang L; Shi W; Song L; Zhang X; Cheng L; Wang Y; Ge X; Li W; Zhang W; Min Q; Jin ZB; Qu J; Gu F
    Sci Rep; 2014 Nov; 4():6936. PubMed ID: 25374051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy.
    Sarzi E; Seveno M; Angebault C; Milea D; Rönnbäck C; Quilès M; Adrian M; Grenier J; Caignard A; Lacroux A; Lavergne C; Reynier P; Larsen M; Hamel CP; Delettre C; Lenaers G; Müller A
    Hum Mol Genet; 2016 Jun; 25(12):2539-2551. PubMed ID: 27260406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel ADOA-associated OPA1 mutation alters the mitochondrial function, membrane potential, ROS production and apoptosis.
    Zhang J; Liu X; Liang X; Lu Y; Zhu L; Fu R; Ji Y; Fan W; Chen J; Lin B; Yuan Y; Jiang P; Zhou X; Guan MX
    Sci Rep; 2017 Jul; 7(1):5704. PubMed ID: 28720802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant optic atrophy: Culprit mitochondria in the optic nerve.
    Lenaers G; Neutzner A; Le Dantec Y; Jüschke C; Xiao T; Decembrini S; Swirski S; Kieninger S; Agca C; Kim US; Reynier P; Yu-Wai-Man P; Neidhardt J; Wissinger B
    Prog Retin Eye Res; 2021 Jul; 83():100935. PubMed ID: 33340656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
    Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
    Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis.
    Olichon A; Landes T; Arnauné-Pelloquin L; Emorine LJ; Mils V; Guichet A; Delettre C; Hamel C; Amati-Bonneau P; Bonneau D; Reynier P; Lenaers G; Belenguer P
    J Cell Physiol; 2007 May; 211(2):423-30. PubMed ID: 17167772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy.
    White KE; Davies VJ; Hogan VE; Piechota MJ; Nichols PP; Turnbull DM; Votruba M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2567-71. PubMed ID: 19234344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function.
    Spinazzi M; Cazzola S; Bortolozzi M; Baracca A; Loro E; Casarin A; Solaini G; Sgarbi G; Casalena G; Cenacchi G; Malena A; Frezza C; Carrara F; Angelini C; Scorrano L; Salviati L; Vergani L
    Hum Mol Genet; 2008 Nov; 17(21):3291-302. PubMed ID: 18678599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.
    Ham M; Han J; Osann K; Smith M; Kimonis V
    Mitochondrion; 2019 May; 46():262-269. PubMed ID: 30165240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.